ARUP Laboratories and PierianDx Create Partnership to Produce More Efficient and Effective Diagnostic Genetic Tests

November 12, 2014

SALT LAKE CITY AND ST LOUIS, MO, US - Nov 12, 2014 - ST LOUIS and SALT LAKE CITY (Nov. 12, 2014) - ARUP Laboratories and PierianDx announced today a partnership that will result in faster and more efficient diagnostic genetic testing for thousands of patients across the U.S.

 

ARUP Laboratories, a leading national reference lab serving many of the nation’s top university teaching hospitals, pediatric hospitals, as well as multi-hospital groups and government facilities, will join the PierianDx partner network to share tools, assays, and clinical information to expedite and improve the personalized interpretation of next- generation sequencing clinical diagnostic tests.

 

ARUP Laboratories will use PierianDx’s proven workflow management tools and next-generation sequencing knowledgebase to more effectively and quickly access its own immense knowledgebase of variants and clinical outcomes, as well as benefit from the collective insights of other institutions in the PierianDx partner network.

 

“Our expectation is that by leveraging PierianDx’s visionary software and database, we will be able to more effectively learn from past assays and provide even more personalized recommendations to physicians so they can better match their patients to the right therapies,” said ARUP President and CEO, Dr. Edward Ashwood.

 

Spun-off earlier this year from Washington University in St. Louis where it was developed and is in active clinical use, PierianDx offers a bioinformatics platform, workflow solution and software along with a knowledgebase of clinical information from thousands of previous genomic tests.

 

“By teaming with ARUP, the PierianDx partner network will benefit from insight provided by ARUP clinical interpretations, variants, and related de-identified patient information,” said Ted Briscoe, CEO of PierianDx. “All of our partners will be able to leverage our expanding knowledgebase to improve personalized diagnosis and care.”

 

 

About PierianDx

 

PierianDx enables clinical labs to deliver patient-specific diagnosis and treatments based on an individual’s DNA. In active use since 2011 by Washington University in St. Louis, PierianDx’s proprietary Clinical Genomicist Workstation software, knowledgebases, IT backbone and workflow management tools provide an end-to-end solution for managing clinical next-generation sequencing processes. For more information, please visit www.pieriandx.com or @PierianDx on Twitter.

 

About ARUP Laboratories

Founded in 1984, ARUP Laboratories is a leading national reference laboratory and a nonprofit enterprise of the University of Utah and its Department of Pathology. ARUP offers more than 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. ARUP serves clients across the United States, including many of the nation’s top university teaching hospitals and children’s hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology®.